United Therapeutics Corp. (UTHR)
536.07
-5.53
(-1.02%)
USD |
NASDAQ |
Mar 26, 12:28
United Therapeutics Cash from Investing (Quarterly) : -227.60M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| MannKind Corp. | -291.96M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Zoetis, Inc. | -166.00M |
| Vera Therapeutics, Inc. | 80.66M |
| Geron Corp. | 21.14M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 346.20M |
| Cash from Financing (Quarterly) | 98.40M |
| Free Cash Flow | 1.035B |
| Free Cash Flow Per Share (Quarterly) | 3.664 |
| Free Cash Flow to Equity (Quarterly) | 173.30M |
| Free Cash Flow to Firm (Quarterly) | 175.84M |
| Free Cash Flow Yield | 4.03% |